Overview

The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects

Status:
Completed
Trial end date:
2019-10-29
Target enrollment:
Participant gender:
Summary
A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Single & Multiple Ascending Dose Study to Access the Tolerability and Pharmacokinetics of HEC110114 Tablets in Healthy Adult Subjects
Phase:
Phase 1
Details
Lead Sponsor:
Sunshine Lake Pharma Co., Ltd.